Dieter Vancraeynest
External Innovation Europe
Zoetis
Zaventem, Belgium
My organisation
About me
My organisation
Zoetis is a leading animal health company whose purpose is to nurture the world and humankind by advancing care for animals.
After 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide - from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with over 14,000 employees.
Zoetis works to help meet two global needs: the growing demand for animal protein and animal companionship.
Research and Development is at the core of our efforts to provide innovation outcomes that anticipate the future needs of veterinarians, pet owners and livestock producers around the world. The Zoetis R&D organization is comprised of scientific experts in numerous disciplines in science and veterinary medicine. These experts leverage state-of-the-art research facilities, the latest technologies and innovative approaches to deliver complete health solutions to vets, 'pet parents' and farmers. We apply our research to a broad and diverse range of species, therapeutic areas and geographic regions. Our R&D activities include the development of vaccines, pharmaceuticals and biopharmaceuticals therapeutics, genetic and diagnostic products as well as biodevices for automated vaccination in poultry and fish. Zoetis is also increasingly delivering data-driven solutions to its customers.
We at Zoetis strive to be the business partner of choice in the vibrant and growing animal health industry. We explore commercial partnerships that help strengthen our diverse portfolio and/or which allow expansion into complementary spaces or geographies. We also seek research collaborations that combine technologies and skills with our in-house capabilities. We engage in open research collaborations with companies and non-commercial groups, such as universities, that have expertise in areas that complement our own.
Speaker sessions (1)
Tuesday, 17 September 2024
16:20 - 16:30
Routes of administration: perspectives from the veterinary field – Dieter Vancraeynest, ZOETIS
The veterinary field is confronted with very diverse animal species and often needs to mass administer vaccines at low cost. This talk will cover various routes of administration – focusing on opportunities and challenges.